|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-cell function in type 2 diabetes
1Copenhagen Muscle Research Centre and 2Department of Medical Physiology, The Panum Institute, University of Copenhagen, 2200 Copenhagen N; 3Clinic for Spinal Cord Injuries and 4Department of Orthopedic Medicine T, Rigshospitalet, 2100 Copenhagen Ø 5Department of Urology, Herlev University Hospital, DK 2730 Herlev; and 6Department of Rheumatology, Bispebjerg Hospital, Bispebjerg, 2400 Copenhagen NV, Denmark
Submitted 4 February 2004 ; accepted in final form 2 July 2004
In healthy young subjects, training increases insulin sensitivity but decreases the capacity to secrete insulin. We studied whether training changes
-cell function in type 2 diabetic patients. Patients, stratified into "moderate" and "low" secretors according to individual C-peptide responses to an intravenous glucagon test, were randomly assigned to a training program [ergometer cycling 3040 min/day, including at least 20 min at 75% maximum oxygen consumption (
O2 max), 5 days/wk for 3 mo] or a sedentary schedule. Before and after the intervention (16 h after last training bout), a sequential hyperglycemic (90 min at 11, 18, and 25 mM) clamp was performed. An intravenous bolus of 5 g of arginine was given at the end. Training increased
O2 max 17 ± 13% and decreased heart rate during submaximal exercise (P < 0.05). During the 3 mo of sedentary lifestyle, insulin and C-peptide responses to the clamp procedures were unchanged in both moderate and low secretors. Likewise, no change in
-cell response was seen after training in the low secretors (n = 5). In contrast, moderate secretors (n = 9) showed significant increases in
-cell responses to 18 and 25 mM hyperglycemia and to arginine stimulation. Glucagon responses to arginine as well as measures of insulin sensitivity and Hb A1c levels were not altered by training. In conclusion, in type 2 diabetic patients, training may enhance
-cell function if the remaining secretory capacity is moderate but not if it is low. The improved
-cell function does not require changes in insulin sensitivity and Hb A1c concentration.
C-peptide; insulin; arginine; hyperglycemic clamp
This article has been cited by other articles:
![]() |
K. R. Kelly, L. M. Brooks, T. P. J. Solomon, S. R. Kashyap, V. B. O'Leary, and J. P. Kirwan The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1269 - E1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
S F E Praet, R A M Jonkers, G Schep, C D A Stehouwer, H Kuipers, H A Keizer, and L J van Loon Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise training Eur. J. Endocrinol., February 1, 2008; 158(2): 163 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kiraly, H. E. Bates, N. A. Kaniuk, J. T. Y. Yue, J. H. Brumell, S. G. Matthews, M. C. Riddell, and M. Vranic Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of {beta}-cell function Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E271 - E283. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park, S. M. Hong, J. E. Lee, and S. R. Sung Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic beta-cell function and mass through IRS2 in diabetic rats J Appl Physiol, November 1, 2007; 103(5): 1764 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Kilpelainen, T. A. Lakka, D. E. Laaksonen, O. Laukkanen, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, S. Aunola, P. Ilanne-Parikka, et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes Physiol Genomics, October 19, 2007; 31(2): 264 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Snowling and W. G. Hopkins Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: A meta-analysis. Diabetes Care, November 1, 2006; 29(11): 2518 - 2527. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E Laaksonen, L. K Toppinen, K. S Juntunen, K. Autio, K.-H. Liukkonen, K. S Poutanen, L. Niskanen, and H. M Mykkanen Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1218 - 1227. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |